glp-1 news today 2025-10-16 Doctors and patients across social media are reporting a kind of emotional flattening while on drugs. Anecdotally, physicians describe meaningful mental health gains — greater self-esteem, less shame over eating and The expanding landscape of GLP-1

Muscle loss is a significant risk with these medications, and its largely preventable with the right approach

Written informed consent was not obtained as the study utilized publicly available aggregate GWAS data

O acmulo de gordura acontece quando as calorias esto em desequilbrio entre o que consumido e o que gasto

The task force has not yet produced public enforcement actions specific to PBMs as of Q1 2026, but its establishment signals that the DOJ views the structural questions around PBM integration as within its antitrust enforcement authority, separate from and parallel to the FTCs consumer protection approach

Injection Protocol : Always use sterile syringes and needles , and follow aseptic technique to reduce the risk of infection or contamination

Additionally, the GLP-1R/glucagon receptor (GCGR) dual agonist, managed by Innovent Biologics and Eli Lilly, has reached Phase III clinical trials in China with type 2 diabetes patients, demonstrating significant reductions in blood sugar, weight loss, and cardiovascular and kidney benefits